Glow Lifetech Reduces Warrant Overhang by 20+ Million as Largest Shareholder Exercises $450k+ At-the-Money Warrants, Bolstering Balance Sheet

Executive Summary

• Glow Lifetech’s largest shareholder exercised 9,050,000 warrants at $0.05 per share, generating $452,500 in cash for the company.
• An additional 11,116,667 warrants expired unexercised, removing roughly 20 million warrants from the capital structure and reducing potential dilution.
• The company settled approximately $50,000 of outstanding debt by issuing 714,286 common shares at a deemed price of $0.07 per share.

Key Details

• Warrant Exercise: 9,050,000 at‑the‑money warrants exercised; proceeds = $452,500 (price $0.05/share).
• Warrant Expiry: 11,116,667 warrants expired on October 26 2025, eliminating ~20 million warrants from the overhang.
• Debt Settlement: Issuance of 714,286 common shares to extinguish ~$50,000 of debt at a deemed price of $0.07 per share. Shares are subject to a four‑month‑plus‑one‑day hold period under Canadian securities regulations.
• Cash Position: The cash received from the warrant exercise bolsters working‑capital flexibility for ongoing operations and growth initiatives.
• Capital Structure Impact: Combined exercise and expiry reduce potential dilution, streamline the capital structure, and improve financial flexibility.

Notable Quotes

“The exercise of warrants by our largest shareholder is a strong endorsement of Glow's progress, strategy, and future potential,” said Rob Carducci, CEO of Glow Lifetech. “Combined with the expiry of additional warrants, these developments strengthen our already strong balance sheet, streamline our capital structure and reduce potential dilution, and position us to continue executing our growth strategy with focus and discipline.”